Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bausch & Lomb Sues Ciba Vision for Infringement of Newly Issued Patent.


Business Editors

ROCHESTER, N.Y.--(BUSINESS WIRE)--July 22, 2003

Bausch & Lomb (NYSE NYSE

See: New York Stock Exchange
:BOL BOL Bolivia (ISO Country code)
BOL Books Online
BOL Bole (SIL code, Nigeria)
BOL Bill Of Lading
BOL Beginning Of Line
BOL Best Of Luck
BOL Buzz Out Loud
BOL Bruin Online
BOL Beginning Of Life
) today filed suit against CIBA Vision, the eyecare unit of Novartis AG, for infringement of U.S. patent no. 6,596,294 which was issued today by the United States Patent & Trademark Office.

The patent relates to chemical compositions useful in contact lenses.

Bausch & Lomb alleges that CIBA's Focus Night & Day contact lenses infringe this patent, which is a continuation of patent 6,312,706, the patent at issue in its pending suit against CIBA CIBA Canadian Intercollegiate Baseball Association
CIBA Chemical Industry in Basle
CIBA Cayman Islands Bankers Association
CIBA Californian Indian Basketweavers Association
 filed in November 2001. Today's suit was filed in the Federal District Court in Rochester, New York This article is about the city of Rochester in Monroe County. For the town in Ulster County, see Rochester, Ulster County, New York.
Rochester, once known as The Flour City, and more recently as The Flower City or
. Bausch & Lomb is seeking a jury trial in this matter, and has requested injunctive relief injunctive relief n. a court-ordered act or prohibition against an act or condition which has been requested, and sometimes granted, in a petition to the court for an injunction.  and monetary damages.

The company said it will continue to vigorously protect and enforce its intellectual property rights, and believes the newly issued patent presents a compelling infringement case against CIBA's Night & Day contact lens contact lens, thin plastic lens worn between the eye and eyelid that may be used instead of eyeglasses. Actors, models, and others wear them for appearance, and athletes use them for safety and convenience. .

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Celebrating its 150th anniversary in 2003, the Company is headquartered in Rochester, New York. Bausch & Lomb's 2002 revenues were $1.8 billion; it employs approximately 11,500 people worldwide and its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb.
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:4EUIR
Date:Jul 22, 2003
Words:274
Previous Article:Multimedia Available: Remote Control Heart Surgery.
Next Article:Insight Announces Proposed Refinancing of Ohio Debt.



Related Articles
Ciba Vision is Forced to Withdraw Its Last-Ditch Effort to Disrupt Launch of Bausch & Lomb's Breakthrough Lens, PureVision.
Bausch & Lomb is Not Deterred by Recent Patent Office Finding Regarding Ciba Patents for Extended Wear Contact Lenses.
Bausch & Lomb Sues Ciba Vision for Patent Infringement; Asks Federal Court to Halt Ciba's Upcoming Launch of Infringing Extended Wear Contact Lens in...
CONTACT LENS MAKER SETTLES PRICING LAWSUIT.
Bausch & Lomb Will Appeal Decision In Ciba Patent Litigation Related to Its Innovative PureVision Continuous Wear Contact Lens.
Bausch & Lomb Responds to Filing Of Patent Infringement Lawsuit in Ireland.
Bausch & Lomb Wins at European Patent Office Hearing.
Bausch & Lomb Files Third Lawsuit Against CIBA Vision For Patent Infringement.
Bausch & Lomb and Oasis Medical Announce Settlement of Patent Infringement Lawsuit.
Bausch & Lomb and CIBA Vision Announce Final Global Settlement of Patent Litigation; Companies Cross-License Rights to Revolutionary Silicone...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles